BeOne Medicines Ltd. 10-Q filing
Filed 2025-08-06 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001651308-25-000133
- Form type
- 10-Q
- CIK
- 0001651308
- Primary document
- https://www.sec.gov/Archives/edgar/data/1651308/000165130825000133/bgne-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BeOne Medicines Ltd..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $2.4B | - | - |
| Gross Profit | $2.1B | - | - |
| Operating Income | $99.0M | - | - |
| Net Income | $95.6M | - | - |
| Eps Basic | 0.07 | - | - |
| Eps Diluted | 0.07 | - | - |
| Cash And Equivalents | $2.8B | - | - |
| Total Assets | $6.3B | - | - |
| Total Liabilities | $2.5B | - | - |
| Shareholders Equity | $3.8B | - | - |
| Operating Cash Flow | $307.7M | - | - |
| Capital Expenditures | $100.2M | - | - |